Nanobiotechnology and Nanomedicine Companies
Showing results 1 - 7 of 7 of companies in France:
The company has developed and produced superparamagnetic nanoparticles for in vitro diagnostic and life sciences.
The company develops clinical diagnostics systems including molecular biology-based assays.
CYTOO focuses on innovative products for the life science research market with an emphasis in cell based assays, high content analysis and cell screening. The company develops, manufactures, and distributes products that make cellular analysis robust and reliable by drastically decreasing cell variability.
Grapheal makes embedded and wearable biosensors, digital by design, minimalistic in components, with capabilities to dose biomarkers and detect pathogens anywhere with a simple smartphone.
The company has developed an innovative cancer treatment using magnetosomes (magnetic nanoparticles synthesized by magnetotactic bacteria), which are administered to tumors and heated by applying an alternating magnetic field. This method of treatment is called magnetic hyperthermia. The heat released by the magnetosomes induces antitumor activity.
Dedicated to finding new treatments for cancer based on the combined application of nanotechnologies and biotechnologies.
OZ Biosciences creates, develops and produces innovative tools based on drug delivery systems for the worldwide scientific community and pharmaceutical industry. OZ Biosciences focuses on technologies for the delivery of bioactive materials into living organisms.